According to a recent LinkedIn post from Infinitus Systems, the company’s CEO and Co-founder Ankit Jain is scheduled to speak at Asembia’s AXS26 Summit in Las Vegas. The session is set to feature a discussion with Optum Rx Chief Information Officer Santiago Abraham on the current realities and limitations of artificial intelligence in healthcare.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests the conversation will focus on what AI can reliably deliver today, which capabilities remain largely hype, and how the technology may evolve next. For investors, this visibility alongside a major pharmacy benefit and healthcare services player such as Optum Rx may indicate Infinitus Systems’ intent to position itself as a credible voice on practical AI deployment in the healthcare sector.
Participation in a high-profile industry summit could help the company deepen relationships with potential enterprise customers and partners in the payer and pharmacy ecosystems. While the post does not disclose commercial agreements or financial metrics, the association with a large industry stakeholder and focus on pragmatic AI use cases may support Infinitus Systems’ efforts to convert interest in AI into scalable adoption, which could be relevant for its long-term growth prospects.
The inclusion of a link detailing “what to expect from Infinitus at AXS26” points to a broader presence at the event beyond the single session. If this presence translates into demonstrations or pilot discussions, it could help the company refine its product-market fit and signal how its AI solutions might address operational pain points in healthcare, an area investors frequently assess when evaluating emerging healthtech platforms.